Comparison of Myelodysplastic Syndrome Prognostic Scoring Systems

Bektas Ö., ÜNER A., Eliacik E., Uz B., Isik A., Etgul S., ...Daha Fazla

TURKISH JOURNAL OF HEMATOLOGY, cilt.33, sa.2, ss.119-126, 2016 (SCI-Expanded) identifier identifier identifier

  • Yayın Türü: Makale / Tam Makale
  • Cilt numarası: 33 Sayı: 2
  • Basım Tarihi: 2016
  • Doi Numarası: 10.4274/tjh.2014.0455
  • Dergi Adı: TURKISH JOURNAL OF HEMATOLOGY
  • Derginin Tarandığı İndeksler: Science Citation Index Expanded (SCI-EXPANDED), Scopus, TR DİZİN (ULAKBİM)
  • Sayfa Sayıları: ss.119-126
  • Anahtar Kelimeler: Myelodysplastic syndrome, International Prognostic Scoring System, MD Anderson Prognostic Scoring System, World Health Organization Classification-Based Prognostic Scoring System, Revised International Prognostic Scoring System, LEUKEMIC EVOLUTION, REFRACTORY-ANEMIA, CLASSIFICATION, RISK, VALIDATION, SURVIVAL, IMPACT, IPSS, MDS
  • Karadeniz Teknik Üniversitesi Adresli: Hayır

Özet

Objective: Myelodysplastic syndrome (MDS) is a clonal hematopoietic stem cell disease. Patients are at risk of developing cytopenias or progression to acute myeloid leukemia. Different classifications and prognostic scoring systems have been developed. The aim of this study was to compare the different prognostic scoring systems.